Frankfurt, Germany | October 28–30, 2025
The global pharmaceutical industry converged once again in Frankfurt this year for CPHI Frankfurt 2025, one of the most influential gatherings in the healthcare and life sciences calendar. The atmosphere was vibrant, with thought leaders, innovators, and regulatory professionals from every corner of the world exchanging ideas on how science, technology, and compliance are shaping the future of medicines.
Amid this global energy, DDReg joined industry peers and partners at the Messe Frankfurt to engage in meaningful discussions on the evolving regulatory landscape and showcase its role as a trusted regulatory affairs and pharmacovigilance partner to global pharma.
A Global Platform for Collaboration
The event hosted more than 62,000 professionals and 2,400 exhibitors representing the full pharmaceutical value chain from API and Biologics developers to CROs, CDMOs, and technology providers.
This year’s focus areas including BioProduction, Contract Services, AI and Digital Solutions, and Sustainable Manufacturing reflected how the industry is adapting to new technologies, global health priorities, and compliance expectations.
For DDReg, CPHI Frankfurt 2025 was an opportunity to engage directly with international stakeholders, explore collaboration possibilities, and exchange insights on digital transformation in regulatory science.
Key Takeaway
The conversations at CPHI Frankfurt 2025 reaffirmed that progress in global pharma depends on collaboration and clarity in regulation. Companies are seeking partners who understand regional nuances and can translate them into globally compliant strategies.
DDReg continues to empower organizations worldwide with regulatory insight, operational precision, and digital excellence.
About CPHI Frankfurt 2025
Organized by Informa Markets, CPHI Frankfurt remains the leading international platform for innovation, partnership, and business growth in the pharmaceutical industry. The 2025 edition brought together experts and decision-makers to discuss the most pressing themes in manufacturing, regulation, and technology.
About DDReg
DDReg is a global life science consulting company providing Regulatory Affairs Services, Pharmacovigilance Services, Clinical Research, and Digital Regulatory Solutions. Operating across 120+ markets, DDReg helps pharmaceutical and biotechnology companies accelerate approvals, maintain compliance, and ensure product safety across regions.
Through its strategic expertise and technology-driven approach, DDReg continues to support its partners in achieving regulatory success and sustainable global growth.
Read more from DDReg: DDReg Honored at ET Health Conclave 2025 for Excellence in Life Sciences Services